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A b s t r a c t
Background: An imbalance between the activity of matrix metalloproteinases (MMPs), particularly gelatinases, and tissue 
inhibitors of metalloproteinases (TIMPs) is considered as one of the mechanisms leading to aortocoronary graft failure.
Aim: We aimed to assess the variability in gelatinase expression in the walls of aortocoronary conduits and to evaluate its 
impact on coronary artery bypass grafting (CABG) outcomes.
Methods: The study included 101 consecutive patients (61 men and 40 women) who underwent CABG. An immunohisto-
chemical analysis of MMP-2, MMP-9, TIMP-1, and TIMP-2 expression was performed on the cross-sections of the internal 
thoracic artery (ITA), radial artery (RA), and saphenous vein (SV). The histological findings were compared between patients 
with SV graft disease (SVGD[+] group) and those without occlusions in the SV (SVGD[–] group).
Results: The median MMP and TIMP expression was the weakest in the ITA wall. MMP expression was comparable between 
the RA and SV cross-sections, whereas TIMP expression was stronger in the RA than in the SV wall (p < 0.05). In most SV 
segments, but not in the arteries, immunostaining intensity for MMP was comparable to or stronger than for TIMPs. In the 
veins harvested from the SVGD(+) group, MMP-2 and MMP-9 tissue expression was more pronounced than in the SVGD(–) 
group. TIMP levels were comparable between groups.
Conclusions: Imbalance in the metalloproteinase-to-inhibitor tissue expression in the vessel wall might predispose to graft 
failure. A stronger expression of TIMPs than MMPs in the arterial grafts might explain favourable long-term outcomes.
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INTRODUCTION
Coronary artery bypass grafting (CABG) is a method of choice 
in the treatment of patients with extensive coronary artery 
disease (CAD) [1]. The late angiographic and clinical outcomes 
depend both on the progression of CAD in the native arteries 
and on the patency of the implanted aortocoronary conduits 
[2, 3]. Although transplantation of the left internal thoracic 
artery (ITA) to the left anterior descending artery has been 
considered as a gold standard for many years, other arterial 
and saphenous vein (SV) segments have been extensively used 
in CABG procedures [4, 5]. Long-term outcomes of the other 
grafts are often conflicting but more reports favour the radial 
artery (RA) as the second-best graft [3, 6].
Investigators have been searching for possible factors 
that might determine the unfavourable outcome of the 
implanted conduits [7, 8]. So far, numerous cell lines and 
bioactive molecules have been implicated. Among others, 
two matrix metalloproteinases (MMPs), namely MMP-2 and 
MMP-9, also known as gelatinases, have been shown to be 
involved in extracellular matrix (ECM) degradation, which is 
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of paramount importance in the promotion of cell migration 
within the vessel wall, followed by neointima formation and 
atherosclerosis [9, 10]. 
The biological activity of these gelatinases is physiologically 
balanced by their tissue inhibitors (tissue inhibitors of metal-
loproteinases [TIMPs]). There is mounting evidence pointing 
towards an imbalance between MMP and TIMP activity, rather 
than the expression of gelatinases themselves, as the deter-
minant of ultrastructural changes within the vessel wall [11].
Considering the above, we assessed the variability in 
gelatinase expression in the walls of the vessels used as aor-
tocoronary conduits, before the CABG procedure, and evalu-
ated whether these differences may have clinical significance.
METHODS
Patients
This study included 101 consecutive patients (61 men and 
40 women) at a mean age of 64.2 ± 9.8 years (range, 42– 
–84 years), who underwent non-emergent CABG. Patients 
were referred for surgery on the basis of coronary angiog-
raphy. At the end of the follow-up, they were classified into 
two subgroups: one with SV graft disease (SVGD[+]) and the 
other without SV graft occlusions (SVGD[–]). Selected baseline 
data are summarised in Table 1.
The study protocol was approved by the Bioethical 
Committee of the Poznan University of Medical Sciences 
(1207/08). All patients gave written informed consent to 
participate in the study.
Biological material procurement and preparation 
During off-pump CABG procedures performed mostly 
(97 operations; 96.3%) by surgeons with at least five years 
of experience in coronary surgery, surplus segments of the 
vessels used as aortocoronary grafts were obtained for ultra-
structural studies. In all cases, the most distal segments, at 
least one centimetre in length, were harvested. Both arteries 
(ITA and RA) were dissected free as pedicled grafts, whereas 
the SV was obtained in the standard manner, applying a full 
skin incision over its entire course. To minimise possible 
injury to the vessels, surgeons avoided touching (no-touch 
technique), excessive manipulation, and dilation or use of 
high-energy electrocautery. As a result, 230 vessel segments 
(101 ITA, 101 SV, and 28 RA segments) were saved for his-
tological analysis.
The segments were subjected to a macroscopic inspection 
for any abnormalities, following which they were carefully 
rinsed with 0.9% NaCl at room temperature, slightly dilated, 
and immersed in the freshly prepared Boiun solution for light 
microscopic studies. The subsequent steps of preparation for 
light microscopic examinations were described in detail previ-
ously [12]. All immunohistochemical analyses were performed 
with Dako REAL EnVision Detection System, Peroxidase/DAB, 
Rabbit/Mouse, K5007 (Dako, Copenhagen, Denmark) and 
were conducted according to the standard procedure [12]. 
The following mouse monoclonal antibodies were used: an-
ti-MMP-2 (dilution 1:50; NB200-114), anti-MMP-9 (dilution 
1:250; NB100-78556), anti-TIMP-1 (1:150; NBP1-96554), 
Table 1. Baseline demographic and clinical characteristics of patients with and without saphenous vein graft disease (SVGD)








Age [years] 64.2 ± 9.8 63.4 ± 10.4 64.5 ± 9.2 NS
Clinical data:
Obesity (BMI > 30 kg/m2) 40 (39.6) 10 (41.6) 28 (38.9) NS
Arterial hypertension 66 (65.3) 20 (83.3) 43 (59.7) 0.035
Insulin-treated diabetes 26 (25.7) 8 (33.3) 15 (20.8) NS
Hyperlipidaemia 41 (40.6) 12 (50.0) 29 (40.3) NS
Renal failure1 13 (12.9) 3 (12.5) 10 (13.9) NS
Peripheral vascular disease 25 (24.8) 6 (25.0) 16 (22.2) NS
Neurological events2 9 (8.9) 2 (8.3) 5 (6.9) NS
Active smoking3 51 (50.5) 15 (62.5) 31 (43.1) NS
Preoperative coronary angiography:
Left main disease 23 (22.8) 5 (20.8) 17 (23.6) NS
Two-vessel disease 15 (14.9) 3 (12.5) 11 (15.3) NS
Three-vessel disease 63 (62.3) 16 (66.7) 44 (61.1) NS
Categorical variables are presented as a number (percentage), and continuous variables as a mean ± standard deviation. BMI — body mass index;  
NS — non-significant
*The sum of SVGD(–) and SVGD(+) patients is not 101 because five patients were lost to follow-up.
1Diagnosed if a glomerular filtration rate was below 60 mL/min/1.73 m2; 2Included both transient ischaemic attacks and strokes; 3The term  
“active smokers” comprises active smokers and the individuals who had given up smoking within one year before surgery
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and anti-TIMP-2 (dilution 1:200; NB110-61001) (all Novus 
Biologicals, Littleton, CO, USA). The peroxidase reaction was 
conducted with the use of diaminobenzidine. 
Immunohistochemical analysis  
of protein expression
Immunohistochemical reactions were analysed using an 
Olympus BX 50 light microscope (OLYMPUS Optical Europe, 
Germany), equipped with a Mirax-Midi scanner (Carl Zeiss 
Microlmaging GmbH, Germany) and compatible with im-
age visualisation software (Pannoramic Viewer ver. 1.15.4.; 
3DHISTECH Ltd., Budapest, Hungary).
The intensity of the cytoplasmic expression of proteins 
was blindly assessed by two experienced histologists on 
10 representative vessel cross-sections, using the semiquanti-
tative immunoreactive score (IRS) according to Remmele and 
Stegner [13]. This scale takes the percentage of positive cells 
(scale from 0 to 4) and the intensity of the colour reaction 
(scale from 0 to 3) into account, with the final score, ranging 
from 0 to 12, being the sum of points given for individual 
traits. According to the IRS, the expression of cytoplasmic 
proteins was considered as negative (IRS 0–1), weak (IRS 2–3), 
moderate (IRS 4–6), or strong (IRS 8–12). 
Postoperative outcomes
All patients were systematically followed in an outpatient 
clinic after discharge. Special attention was paid to symptoms 
of CAD progression. The composite primary clinical endpoint 
comprised cardiac-related death, acute coronary syndrome, 
or the necessity to undergo coronary angiography due to 
progression of angina, according to the Canadian Cardiovas-
cular Society score. No follow-up angiography was performed 
in asymptomatic individuals, except patients with diabetes, 
who had control coronary angiography irrespective of CAD 
symptoms. Patients who reached the primary endpoint and 
had occlusions in the SV grafts were assigned to the SVGD(+) 
group, whereas the remaining patients were assigned to the 
SVGD(–) group. The histological findings for the graft segments 
were compared between groups.
Statistical analysis
Continuous variables were checked for normality with the 
Shapiro-Wilk W test. If they met the criteria of normal distri-
bution, they were expressed as means with standard devia-
tions. Categorical variables (IRS) were presented as medians 
with the 25th and 75th percentiles. Dichotomous data were 
expressed as absolute numbers (n) with percentages (%), 
and, similarly to the medians, they were compared using the 
Kruskal-Wallis test and, if necessary, with multiple comparisons 
of mean ranks for all groups. 
Vascular segments harvested from the SVGD(+) and 
SVGD(–) groups were compared, and the results were anal-
ysed using the unpaired Student t test or the nonparametric 
Mann-Witney U test. Baseline clinical data (as dichotomous 
variables) of SVGD(–) and SVGD(+) groups were compared 
using the c2 test. A p-value of less than 0.05 was considered 
significant. The analysis was performed with the use of the 
Statistica 10.0 software for Windows (StatSoft, Inc., Tulsa, 
OK, USA).
RESULTS
Tissue expression of gelatinases
The median MMP-2 and MMP-9 expression in vessel cross-sec-
tions differed significantly between the types of vessels (Table 2). 
The weakest expression was observed in ITA walls, whereas 
the RA and SV segments presented comparable results (Fig. 1).
No MMP-9 expression (IRS 0–1) was noted in the 
majority of ITA cross-sections (66; 65.3%), as com-
Table 2. Results of matrix metalloproteinase (MMP) expression analysis
ITA (n = 101) RA (n = 28) SV (n = 101) Statistical analysis***
Tissue expression of proteins (IRS score):*
MMP-2 1 (0; 2) 4 (2; 4) 4 (2; 4) ITA < RA = SV
MMP-9 2 (1; 4) 3.5 (2; 4) 4 (2; 4) ITA < RA = SV
TIMP-1 2 (1; 2) 4 (2; 4) 2 (2; 4) ITA < SV < RA
TIMP-2 4 (4; 4.5) 6 (6; 6.5) 6 (4; 6) ITA < RA < SV
Tissue expression of MMPs vs. TIMPs:**
MMP-2 > TIMP-1 11 (10.9) 5 (19.2) 53 (52.5) ITA < RA = SV 
MMP-2 > TIMP-2 0 (0) 1 (3.8) 38 (37.6) NS
MMP-9 > TIMP-1 29 (28.7) 7 (26.9) 23 (22.8) ITA = RA < SV
MMP-9 > TIMP-2 0 (0) 0 (0) 7 (6.9) NS
*Data (IRS according to Remmele score) are expressed as medians (25th; 75th percentile) or ** numbers [n] with percentage; *** ”<” if p value < 0.5; 
IRS — immunoreactivity score; ITA — internal thoracic artery; NS — non-significant; RA — radial artery; SV — saphenous vein; TIMP — tissue 
inhibitor of metalloproteinase
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Figure 2. Expression of tissue inhibitors of metalloproteinases (TIMPs). The weakest immunostaining for TIMP-1 (A, C, E) and 
TIMP-2 (B, D, F) was seen in the tunica media (Med) of the internal thoracic artery (ITA) cross-sections; moderate, in saphenous 
vein (SV) wall; and the strongest, in radial artery (RA) segments. TIMP-2-positive cells were also found in the wall of the vasa 
vasorum (arrows) on RA and SV cross-sections; Adv — tunica adventitia; Int — tunica intima
Figure 1. Matrix metalloproteinase (MMP) expression in the arterial wall. Intensity of immunostaining for MMP-2 (A, C) and 
MMP-9 (B, D) observed in the tunica media (Med) of the internal thoracic artery (ITA) cross-sections was much weaker than in 
saphenous vein (SV) wall. MMP-2-positive cells were also found in the wall of the vasa vasorum (arrows) on SV cross-sections; 














Bartłomiej Perek et al.
220
pared with approximately 10% (n = 3) of RA and 15% 
(n = 15) of SV segments. A detailed analysis revealed that 
the MMP-2-positive ITA specimens were harvested from 
younger patients than the MMP-2-negative vessels (mean 
age, 62.2 ± 11.6 years vs. 66.8 ± 5.9 years; p = 0.001). 
Contrary to the arterial segments, the MMP-2-positive SV 
segments were obtained from older patients (mean age, 
72.3 ± 10.3 years) than the MMP-2-negative veins (mean 
age, 58.9 ± 6.6 years; p < 0.001), although the latter group 
was relatively small (only 15 patients). Regarding MMP-9, 
immunostaining was positive in all RA and SV segments, as 
compared to less than 60% (n = 59) of the ITA cross-sec-
tions. The MMP-9-negative ITA segments were obtained from 
younger patients than the MMP-9-positive segments (mean 
age, 60.7 ± 10.6 vs. 66.1 ± 9.1 years; p = 0.001).
Tissue inhibitors of metalloproteinase expression
The weakest TIMP-1 and TIMP-2 expression was observed for 
the ITA; moderate, for the SV; and the strongest, for the RA 
(Table 2, Fig. 2). Moreover, the ITA was the only vessel type for 
which neither TIMP-1 (n = 34; 33.7%) nor TIMP-2 (n = 10; 
9.9%) immunoreactivity was seen on some cross-sections 
(IRS 0–1). The difference in global tissue expression of both 
TIMP-1 and TIMP-2 on the SV and RA cross-sections probably 
resulted from a stronger TIMP expression in the tunica media 
of the RA (p < 0.001; RA vs. SV). 
Balance of MMP and TIMP expressions 
The immunohistochemical analysis revealed a stronger 
expression of MMPs than TIMPs only in 30% of the arterial 
(both ITA and RA) cross-sections. In the majority of the SV 
segments, MMP tissue expression was comparable to or 
stronger than that of TIMPs. The only exception was the 
MMP-9-to-TIMP-2 ratio. The results are presented in Table 2.
Late survival and adverse cardiac events
Six (5.9%) individuals were lost to follow-up (mean follow-up 
duration, 7.4 ± 2.7 years). Death was reported for 17 patients, 
including 10 patients who died due to cardiac reasons (acute 
coronary syndrome [n = 7] or progressive left ventricular 
heart failure [n = 3]). The mean probability of 12-, 36-, 
and 60-month survival was 95.0% ± 2.2%, 90.0% ± 2.9%, 
and 84.9% ± 3.6%, respectively. Moreover, in 20 patients, 
symptomatic CAD progression was noted. The mean survival 
rate without CAD progression, estimated according to the 
Kaplan-Meier curve, was 91.1% ± 2.8%, 78.2% ± 4.1%, and 
67.3% ± 4.7%, at 12, 36, and 60 months, respectively (Fig. 3).
Patients with CAD progression
Based on the clinical status, 30 patients underwent emergent 
or elective coronary angiography. Additionally, in 20 asymp-
tomatic patients, coronary angiography was performed but 
no progression of CAD was observed. Only in five patients, 
CAD progression was observed in the native coronary arteries, 
which had not been treated during the primary surgery, result-
ing in clinical deterioration. In the remaining patients (n = 25), 
significant graft occlusions were observed, particularly in the 
SV segments (n = 24), followed by the RA (n = 4) and ITA 
(n = 2) grafts. Detailed results of the follow-up coronary 
angiography are shown in Table 3.
Due to a small number of the arterial conduits with 
significant lesions at the end of follow-up, only histological 
parameters of the SV conduits were compared. In the vessel 
segments harvested from SVGD(+) individuals, a markedly 
stronger tissue expression of both MMPs and a comparable 
TIMP expression was observed as compared with the SVGD(–) 
group (Table 4).
DISCUSSION
In this study we showed the variability in the expression 
of gelatinases (MMP-2 and MMP-9) and their inhibitors 
(TIMP-1 and TIMP-2) in the walls of vessels routinely used 
by cardiac surgeons as aortocoronary conduits. Moreover, 
we observed that tissue expression of MMPs is usually better 
balanced by TIMPs in the arteries than in the veins. These 
findings may have clinical significance and might have an 
impact on the long-term outcomes of the implanted grafts. 
Figure 3. Coronary artery disease progression-free survival
Table 3. Results of follow-up coronary angiography 
Significant lesions Follow-up coronary angiography
No CAD progression 20
Native coronary arteries 5
SV 21
SV + RA 2
SV + RA + ITA 2
RA 1
Data are expressed as the number of patients. CAD — coronary artery 
disease; other abbreviations — see Table 2
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This report is part of a larger project aimed at supporting 
cardiac surgeons in decision making as to the optimal choice 
of vessels to bypass stenotic or occluded coronary artery seg-
ments. Although the effect of the demographic and clinical 
variables such as age, sex, quality of the native coronary arteries, 
or concomitant disorders on long-term outcomes of CABG has 
been examined for many years, we are convinced that a care-
ful selection of conduits based on their biological properties is 
particularly important for procedural success [14, 15]. 
To our knowledge, we are the first to show that the 
preprocedural tissue expression of gelatinases was the 
weakest in the ITA walls compared with the other vessels, 
either arterial (RA) or venous (SV), which is one of the key 
histological findings in this study. Additionally, MMP-negative 
cross-sections were observed more frequently for the ITA than 
for the RA or SV. Gelatinases play a major role in the migra-
tion and proliferation of vascular smooth muscle cells, the key 
processes in neointima formation and atherosclerosis. Before 
migration of vascular smooth muscle cells, the surrounding 
ECM scaffold must be degraded by MMPs [16]. The gelati-
nases MMP-2 and MMP-9 have a unique ability to degrade 
elastin and collagen, the main components of the ECM [17]. 
Thus, they enable cell migration from the tunica media to the 
tunica intima through the internal elastic lamina. This leads 
to neointima formation that precedes the development of 
atherosclerosis. These pathological processes are observed 
both in damaged arterial walls (for example, after angioplasty 
for stenosis treatment) and in venous grafts implanted into 
arterial circulation [12, 18]. This leads to complete occlusion 
and clinical disease recurrence. Thus, our finding indicating 
a stronger expression of MMPs in the RA or SV than in the 
ITA wall may explain the lowest rate of ITA graft occlusion 
during  follow-up and, consequently, the most favourable 
long-term outcomes [4]. 
Our study also showed significant differences in TIMP ex-
pression in the walls of vascular segments. Under physiological 
conditions, a proteolytic activity of MMPs is strictly controlled 
by endogenous TIMPs [19]. Interestingly, we observed the 
lowest TIMP activity in the ITA, moderate in the SV, and the 
highest in the RA cross-sections. A previous study describing 
the effects of antiproliferative strategies reported a higher 
TIMP expression in successfully treated vessels [18]. Thus, the 
stronger immunostaining for TIMPs in the RA wall cells than in 
the SV sections observed in our study seems to have positive 
implications. It may at least partially explain why the use of 
RA grafts for CABG results in a lower rate of adverse cardiac 
events and a higher rate of patency in long-term follow-up 
than SV segments [3]. However, the marked differences in 
TIMP expression between grafts may raise some doubts as to 
the use of ITA segments. We believe that it is more important 
to analyse the balance of MMP-to-TIMP tissue expression than 
to assess MMP or TIMP activity separately, because the balance 
between MMP and TIMP expression has been found to be 
involved in maintaining normal structure and function of the 
vessels. This tissue remodelling, involving MMPs and TIMPs, 
has been considered a normal dynamic biological process 
[20]. On the other hand, an imbalance between MMP or 
TIMP activity was noted to be a factor underlying a number 
of vascular pathologies [19, 21]. In our study, the balance 
between MMP and TIMP expression differed between the 
vessels used as aortocoronary bypass grafts. Although tissue 
expression of both TIMPs in the ITA cross-sections was the 
weakest, it was probably high enough to balance the minimal 
MMP activity. More importantly, tissue expression of MMPs 
calculated according to the IRS was usually weaker than that of 
TIMPs, or was at least balanced in the ITA cross-sections. The 
same was observed for RA segments but the absolute value 
of MMP and TIMP expression was stronger than that in the 
ITA wall. Contrary to the arterial grafts, the SV cross-sections 
showed a similar MMP expression but reduced TIMP activity 
compared with the RA, suggesting an imbalance that favoured 
MMP expression. It may at least partially explain why the 
long-term outcomes of the ITA are generally better compared 
with the other grafts and why the RA seems to be favoured 
over the SV [22, 23].
In our study, we also analysed long-term outcomes of 
CABG. We confirmed the previous findings showing that 
clinical deterioration after surgery is determined by unfavour-
able changes in aortocoronary grafts, predominantly in the 
SV segments [2]. In our group, in 21 of the 30 (70%) patients 
with CAD progression after CABG, significant lesions in the 
SV grafts were responsible for clinical deterioration. Moreover, 
the comparison of the SVGD(+) and SVGD(–) groups revealed 
the importance of the absolute value of MMP expression and 
the imbalance between MMP and TIMP activity. Thus, our 
study provides some additional data on the tissue and cellular 
levels, supporting recommendations for CABG that promote 
arterial revascularisation [24].
Table 4. Comparison of matrix metalloproteinase (MMP) and 
tissue inhibitor of metalloproteinase (TIMP) tissue expression in 
saphenous vein (SV) grafts between patients with and without 
saphenous vein graft disease (SVGD)





MMP-2 [IRS] 6 (6; 6) 4 (2; 4) < 0.001
MMP-9 [IRS] 4 (4; 4) 3 (2; 4) 0.005
TIMP-1 [IRS] 2 (2; 4) 2 (2; 4) 0.121
TIMP-2 [IRS] 6 (6; 6) 6 (4; 6) 0.139
MMP-2/TIMP-1 2.0 (1.5; 3.0) 1.0 (0.5; 2.0) < 0.001
MMP-2/TIMP-2 1.0 (1.0; 1.0) 0.7 (0.3; 1.0) < 0.001
MMP-9/TIMP-1 2.0 (1.5; 2.0) 1.0 (1.0; 2.0) 0.001
MMP-9/TIMP-2 0.7 (0.7; 1.0) 0.7 (0.5; 1.0) 0.613
Variables are presented as medians (25th; 75th percentile).  
IRS — immunoreactivity score according to Remmele method
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Our study has several limitations. Frist, not all patients 
who were included in the study underwent control coronary 
angiography. However, it is unlikely that non-diabetic patients 
without clinical progression of CAD had significant stenosis or 
occlusions in aortocoronary grafts. Such findings were previ-
ously reported by our team [12, 25]. Favourable long-term 
outcomes of arterial grafts, particularly the ITA, make it 
difficult to define the predictors of premature graft disease 
and failure. Such an analysis, although on a small number of 
vascular segments, was possible only for venous grafts. Thus, 
our conclusions need to be supported by studies involving 
more patients, particularly with occlusions in aortocoronary 
conduits. Moreover, the immunohistological analysis of the 
protein expression was performed soon after harvesting and 
before implantation into aortocoronary circulation. Ideally, 
such an analysis would be performed on the grafts explanted 
after a given period of time. However, this would be possible 
only in experimental animal models. 
Another limitation is the fact that the ITA is exceptional in 
that it is elastic in its proximal and medial portions, less elastic 
close to its bifurcation, and its distal branches are fully mus-
cular. More importantly, the internal elastic membrane loses 
its dense structure in the distal portion, becoming more per-
meable to infiltrating cells and less resistant to atherosclerotic 
degeneration [26]. The same changes may occur a result of 
age-related biophysical remodelling [27]. Thus, the distal part 
of the ITA should not be treated as representative for the whole 
length of the artery. Finally, tissue expression was assessed on 
the basis of immunohistochemistry. Although this method is 
accepted as a scientific tool to evaluate protein expression, it 
is qualitative rather than quantitative. While the IRS improves 
the quality of the analysis, a high level of scientific expertise 
is still needed. Involved in this project were histologists with 
considerable expertise, substantiated by a strong track record 
of peer-reviewed publications [8, 12]. 
In conclusion, gelatinase expression varies between the 
vessels used as aortocoronary conduits. An imbalance in the 
local haemostasis, favouring metalloproteinases over their tis-
sue inhibitors in the wall of vessels before their application in 
patients undergoing CABG, might predispose to earlier graft 
failure. Higher expression of TIMPs compared with gelatinases 
in arterial grafts might explain their favourable long-term out-
comes. However, further studies on a larger group of patients 
with occlusions in aortocoronary grafts and with long-term 
follow-up are needed to confirm our primary results.
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